ILI. V. Leshchenko

I. V. Leshchenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


I. V. Leshchenko has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Villous chorion remodelling in term placentas following maternal COVID-19 infection: Association with the duration of the post-COVID interval

    by Tetiana Savchuk, Ivan Leshchenko

    Relevance. In placental tissue, SARS-CoV-2 targets cells characterised by the expression of angiotensin-converting enzyme 2 (ACE2), particularly endothelial cells, syncytiotrophoblasts and telocytes. Damage to these cells causes pyroptosis, inflammation and the development of arteriolosclerosis. Telocyte injury is associated with the loss of intercellular signalling, which leads to pathomorphological changes in the placenta. Aim. To investigate the remodelling of the villous chorion in pregnant women with coronavirus disease COVID-19. Materials and methods. A total of 152 placentas from term deliveries in women with COVID-19 were examined and divided into groups according to the duration of the post-COVID interval (from COVID-19 diagnosis to delivery). In Group I (n = 86), the PCI was 1-4 weeks, while in Group II (n = 66), it was 5-18 weeks. The control group comprised 50 placentas obtained after physiological deliveries before the onset of the COVID-19 pandemic. Microscopic, immunohistochemical and statistical research methods were used. COVID-19 in pregnant women was confirmed by a positive polymerase chain reaction (PCR) test for SARS-CoV-2 RNA, while the newborns were PCR-negative and had high Apgar scores. Quantitative differences in the stroma and vessels of the chorionic villi, as well as the percentage of stem and semi-stem chorionic villi, were determined using the ONLINE JPG TOOLS service. Results. The placentas in Group II were characterised by an increased percentage of stem and semi-stem chorionic villi: 33 (23; 47) versus 7 (7; 9); p < 0.001 in Group I. Disorders of the rheological properties of blood were observed in the main groups in the form of stasis and thrombosis in 100% of cases in Group I and 79% of cases in Group II. Stromal oedema led to changes in the ratio of vessels to stroma in the chorionic villi and to a reduction in the percentage of vessels: 29 (27-33). In Group II, the vascular lumen was restored – 46 (44-47), which was explained by a decrease in stromal oedema. Arteriolar endothelial necrosis was detected in 97.7% of observations in Group I and 6.1% in Group II. In Group I, destructive changes in telocytes were identified. In Group II, telocyte-like cells expressing α-SMA were detected, which does not exclude a transition to a myofibroblast phenotype during stromal remodelling in pregnant women with COVID-19, while fibrosis of the villous stroma may indicate transition towards fibroblasts. Compensatory mechanisms in the form of focal formation of small terminal villi were observed in cases involving the birth of infants with high Apgar scores.

  • Open Access

    Remodeling of the villous chorion in pregnant women at 19–25 weeks of gestation after coronavirus disease (COVID-19) in cases of live-term fetal birth and antenatal fetal death

    by T. V. Savchuk, I. V. Leshchenko

    Aim. To investigate the features of villous chorion remodeling after coronavirus disease (COVID-19) at 19–25 weeks of gestation in cases of live-term fetal birth and antenatal fetal death. Materials and methods. The study included placentas from live-born infants (Group I, n = 92), placentas from cases of antenatal fetal death (Group II, n = 12), and a comparison group comprising placentas from live-born infants (n = 54) as well as placentas from cases of antenatal fetal death, subdivided into subgroup I-A (ischemic placental dysfunction) and subgroup II-A (placentitis). Maternal COVID-19 infection was confirmed by a positive polymerase chain reaction test detecting SARS-CoV-2 RNA. Histological examination, immunohistochemistry using monoclonal antibodies against CD31 and α-smooth muscle actin (α-SMA), morphometric analysis, and statistical methods were performed. Results. In Group II and subgroups I-A and II-A, the gestational age was lower compared with Group I and the control group (p < 0.001). Placental examination in Groups I and II and subgroup I-A revealed an increased proportion of stem and intermediate villi – 33 (23; 46), 36 (25; 50), and 30 (22; 48), respectively – and a decreased proportion of terminal chorionic villi – 17 (15; 18), 8 (7; 8), and 10 (9; 14), respectively (p < 0.001). In the capillary walls of terminal villi in Groups I and II, α-SMA-positive pericytes were identified, indicating the acquisition of myofibroblast-like properties. In Group I, vascular remodeling of the stem villi was characterized by smooth muscle cell proliferation and their transition to a synthetic phenotype. In Group II and subgroup I-A, degenerative changes in the smooth muscle cells of stem villous arterioles and pathological neovascularization of obliterated vessels were observed. Placentas from pregnancies complicated by COVID-19 were characterized by stromal edema of the terminal villi, proliferative changes in the vascular wall (Group I), and a high density of obliterated vessels together with stromal fibrosis of the stem villi (Group II). Conclusions. Remodeling of the villous chorion in pregnant women at 19–25 weeks of gestation after COVID-19 was characterized by delayed development. Structural changes in the vascular and stromal components of the villi were associated with transformation of the phenotypic characteristics of smooth muscle cells and pericytes. COVID-19 in pregnant women at 19–25 weeks of gestation induced the development of distinct morphological changes resembling those observed in placental ischemic dysfunction.

  • Open Access

    MORPHOGENESIS OF CHORIONIC VILLI IN PREGNANT WOMEN WITH CORONAVIRUS DISEASE (COVID-19)

    by T. Savchuk, I. Leshchenko

    Villous chorion formation proceeds throughout gestation, encompassing stem, intermediate, and terminal villi. Exposure to adverse factors during pregnancy induces structural chorionic alterations that persist until delivery. SARS-CoV-2, the causative agent of coronavirus disease (COVID-19), directly activates endothelial cells, inducing microcirculatory disturbances alongside proliferative and inflammatory changes. Placental barrier integrity, nevertheless, permits delivery of neonates without detectable SARS-CoV-2 RNA by PCR and devoid of clinical signs of infection. Objective. To investigate chorionic villi morphogenesis in pregnancies complicated by COVID-19. Placentas from pregnancies with confirmed maternal COVID-19, resulting in live-born, term neonates who were SARS-CoV-2 RNA-negative by PCR and presented with high Apgar scores, were examined (n = 144). Study groups were stratified according to the post-COVID interval (PCI), defined as the duration between maternal COVID-19 diagnosis and delivery. Group I (n = 77) comprised cases with PCI of 1–4 weeks, whereas Group II (n = 67) included those with PCI of 5–17 weeks. For comparison, placentas from physiological deliveries before the COVID-19 pandemic were analyzed (n = 53). Microscopic examination, immunohistochemical analysis with monoclonal antibodies against CD31 and smooth muscle actin (α-SMA), and statistical evaluation were performed. Quantification of the vascular component within chorionic villi and the percentage of stem and intermediate villi were assessed using the ONLINE JPG TOOLS service. The study was approved by the Bioethics Committee of Bogomolets National Medical University (Protocol No. 144, dated March 29, 2021). Statistical analysis was performed with SPSS IBM v.22 (Armonk, NY, USA). Descriptive statistics were presented as median with interquartile range (Me [Q1; Q3]). Differences between groups were assessed using the nonparametric Kruskal–Wallis test. A p-value < 0.05 was considered statistically significant. R&D project: “Study of morphogenesis and optimization of morphological diagnostics of the most common socially significant diseases” (State Registration No. 0124U000022, 2024–2026). Results. Necrotic changes affecting the vascular endothelium of chorionic villi were observed in 98% of Group I cases, versus 6.1% in Group II. Stromal edema was present in all cases of Group I, accompanied by narrowing of the vascular lumen and a reduced vascular proportion in terminal villi to 29 (27–33) versus 68 (65–70) in the comparison group (p<0.001). In Group II, the vascular proportion increased to 46 (44–47). In stem (intermediate) villi, the arteriolar lumen diameter was reduced to 32 [18; 42] in Group I and 37 [14; 47] in Group II, compared with 48 [18; 80] in the comparison group (p<0.05). Arteriolar wall thickening corresponded to proliferative changes. Within the stroma of stem (intermediate) villi in Group I, telocyte-like cells exhibiting elongated morphology were observed, demonstrating negative or weak α-SMA expression. In Group II, cells with elongated α-SMA-positive processes corresponding to myofibroblasts were identified. Stromal fibrosis of stem and intermediate villi was identified in 89.4% of Group II cases compared with 4.7% in Group I; concomitantly, the proportion of these villi rose to 33 (23–47), versus 7 (7–9) observed in Group I and the comparison group, while the number of terminal villi was reduced in Group II. Conclusions. COVID-19 during pregnancy induces remodeling of the villous chorion. Endothelial injury constitutes a central feature of this morphogenetic process, triggering phenotypic cellular transformation. Compensatory placental responses, including gradual restoration of endothelial integrity, vascular lumen, and focal hypoplasia of terminal villi, underlie the favorable neonatal outcomes reflected in high Apgar scores.

  • Open Access

    Pathomorphological ultrastructural changes in the placenta in coronavirus disease 2019 (COVID-19) during pregnancy: a literature review

    by T. V. Savchuk, I. V. Leshchenko

    Aim. Based on the analysis of literature data, to investigate the pathomorphological and ultrastructural changes in the placenta associated with COVID-19 during pregnancy, with the identification of critical periods for fetal development. Materials and methods. A search for original research articles was conducted in the scientometric databases PubMed, Web of Science, Scopus, and Google Scholar published between 2017 and 2025. The following search terms were used: COVID-19, SARS-CoV-2, placenta, pregnancy, chorionic villi, and placental telocytes. A total of 44 publications were selected to summarize current knowledge on the issue. Results. According to the literature, during the acute phase of COVID-19 in pregnant women, 100 % of cases showed placentitis, signs of endothelial dysfunction, damage to the microcirculatory bed, edema of the chorionic villi stroma, nuclear apoptosis, narrowing of the vascular lumen, and destructive changes in telocytes. As the post-COVID interval lengthened, manifestations of placentitis decreased and vascular lumens were restored (in cases of COVID-19 during the third trimester). In contrast, cases of infection in the second trimester were characterized by arteriolosclerosis, stromal fibrosis of the villi, and delayed chorionic maturation. Conclusions. Vertical transmission of SARS-CoV-2 from infected pregnant women to their fetuses has been demonstrated, with no established correlation between the severity of maternal illness and the extent of placental or fetal impairment. The SARS-CoV-2 virus causes endothelial dysfunction, microcirculatory disturbances, edema, and placentitis, acting as a morphogenetic factor in chorionic remodeling. The degree of placental pathomorphological changes and the consequences for the fetus were determined by the gestational age at which maternal infection occurs. The loss of regulatory control by structurally damaged telocytes over angiogenesis, vascular tone regulation, and apoptosis constitutes one of the mechanisms underlying the development of placental insufficiency.

  • Open Access

    QUANTITATIVE DETERMINATION OF DELAYED MATURATION OF CHORIONIC VILLI IN THE PLACENTA IN PREGNANT WOMEN WITH COVID-19

    by T. Savchuk, I. Leshchenko

    The structure of the chorion changes according to gestational age, including stem, intermediate, and terminal villi. In the placenta, SARS-CoV-2 affects cells expressing angiotensin-converting enzyme 2 (ACE2), including endothelium and syncytiotrophoblasts. Damage to these cells triggers pyroptosis, inflammation, and arteriolosclerosis. During its maturation, the placenta records and preserves these changes, manifested as impaired chorionic villus formation.Objective. To quantitatively assess delayed maturation of the villous chorion in pregnant women with COVID-19.Materials and Methods. 102 placentas from COVID-19-positive pregnancies were examined: Group I (n=90) – placentas from live term births during the acute phase of maternal disease, and Group II (n=12) – placentas from antenatal fetal asphyxia. In Group II, maternal infection occurred at 17–22 weeks of gestation. For comparison, 50 placentas from physiological term deliveries before the COVID-19 pandemic were analyzed. Microscopic, immunohistochemical, and statistical methods were used. Histological slides were photographed with a digital camera through a microscope, and images were analyzed in JPEG format using ONLINE JPG TOOLS to quantify the percentage of pixels corresponding to the structure of interest.Results. In Group II (antenatal fetal asphyxia), there was an increased proportion of stem and intermediate chorionic villi – 36 (25–50) vs. 7 (6–9) in Group I. Stem villi in Group II exhibited qualitative changes, including stromal fibrosis and arteriolosclerosis. The number of terminal villi in Group II was 8 (8–8); p<0.001. In Group I, the number of terminal villi did not differ from the comparison group – 26 (25–27), indicating appropriate villous chorion formation for gestational age. Despite similar numbers of terminal villi in Groups I and the comparison group, the inter-villous space percentage was reduced in Group I – 26 (20–33) vs. 44 (40–49) in the comparison group, indicating edema of terminal villi. A decreased number of villi in Group II led to an increased inter-villous space – 49 (44–55).Conclusions. A quantitative assessment of placental structures was performed in the acute phase of coronavirus disease in cases of live term birth and in cases of antenatal asphyxia following infection at 17–22 weeks of gestation. The basis of placental insufficiency is qualitative and quantitative remodeling of the chorion. Distal villous hypoplasia chorionic villi in cases of antenatal fetal death are a manifestation of SARS-CoV-2–induced injury to stem and semi-stem villi during the second trimester of gestation.

  • Open Access

    Coronavirus disease 2019 (COVID-19) in pregnancy: pathomorphological ultrastructural changes of the placenta

    by T. V. Savchuk, I. V. Leshchenko, V. V. Vaslovych, O. H. Chernenko, T. A. Malysheva

    Aim. To investigate ultrastructural changes in the placenta of pregnant women with COVID-19 during the second and third trimesters of gestation. Materials and methods. A total of 128 placentas from pregnant women with a confirmed positive PCR test for SARS-CoV-2 RNA were examined. Group I – placentas after live births (n = 94; gestational age 40 ± 2 weeks). Group II – placentas after antenatal fetal death (n = 34; gestational age 33 ± 4 weeks). Based on the post-COVID interval (the time between maternal COVID-19 diagnosis and delivery), the following subgroups were formed: in I.1 (n = 54) and II.1 (n = 12), the post-COVID interval was 5–16 weeks; and in I.2 (n = 40) and II.2 (n = 22), it was 1–4 weeks. For comparison, placentas from physiological deliveries before the COVID-19 pandemic were analyzed (n = 50; gestational age 39 ± 1 week). Macroscopic, microscopic, electron microscopic, morphometric, and statistical analyses were performed. Results. Results. In 100 % of cases, placentitis, endothelial dysfunction, and microcirculatory damage were observed. During the acute phase of COVID-19, cytoplasmic edema of endothelial cells, disruption of cell membranes, and nuclear apoptosis were detected, along with stromal edema of chorionic villi, narrowing of vascular lumina, and destructive changes in telocytes (TCs). With a longer post-COVID interval, Group I showed a decrease in placentitis and stromal edema, as well as restoration of endothelial function and vascular lumina. In Group II, however, arteriolosclerosis, stromal fibrosis, and impaired villous maturation were identified. Conclusions. The effect of SARS-CoV-2 in all groups caused edema and irreversible changes in the endothelial cells of chorionic villous vessels during the acute phase of the disease. The morphogenesis of SARS-CoV-2-induced placental dysfunction involved endothelial dysfunction, impaired microcirculation, inflammatory infiltration, stromal edema of terminal villi followed by fibrosis, narrowing of vascular lumina, and a reduction in the proportion of free intervillous space. Microcirculatory disturbances and stromal villous edema in COVID-19 led to destructive changes in TCs, thereby limiting adequate angiogenesis and regulation of vascular tone in immature intermediate villi. Irreversible alterations of TCs, their fibroblastic differentiation, and subsequent stromal fibrosis of stem and intermediate villi resulted in a reduced number of terminal villi and a dissociated disordered villous maturation.


  • Open Access

    Coronavirus disease 2019 (COVID-19) or preeclampsia: pathomorphological differential diagnosis of placental changes

    by T.V. Savchuk, I.V. Leshchenko

    Coronavirus disease 2019 (COVID-19) and preeclampsia (PE) have shared clinical and pathological manifestations, creating a diagnostic challenge. The aim of the study was to identify pathomorphological changes in the placenta that are diagnostically significant for COVID-19 and preeclampsia. We studied the placenta in full-term pregnancies with maternal COVID-19 (Group I, n=80; Subgroup I.1 – COVID-19 at 19–34 weeks of gestation, n=48; Subgroup I.2 – COVID-19 at 35–40 weeks, n=32), the placenta in cases of preeclampsia (PE, n=30) – Group II (Subgroup II.1 – with mild PE; Subgroup II.2 – with moderate and severe PE), and the placenta in the comparison group, n=40. Macroscopic, microscopic, immunohistochemical, morphometric, and statistical methods were used. Placentae in the main groups were characterized by circulatory disorders. Placentitis was present exclusively in Group I. Arteriolosclerosis with vascular lumen obliteration was predominantly detected in Group II and was associated with arteriolar wall hyalinosis: Subgroup II.1 – 75% (95% CI: 49.5%–93.5%), Subgroup II.2 – 100% (95% CI: 87.3%–100%) compared to 25% (95% CI: 13.6%–38.4%) in Subgroup I.1, where it was caused by the proliferation of smooth muscle cells in the arteriolar wall followed by fibrosis, and was not observed in Subgroup I.2. A reduction in the number of terminal chorionic villi was observed in Subgroup I.1 and Subgroup II.2: 16.6 [10; 25] and 12.8 [12; 14], respectively. This was attributed to delayed villous maturation caused by vascular damage in the stem villi. The placenta in Subgroup I.2 was characterized by stromal edema of terminal villi, which led to external compression of the vessels, resulting in a reduced percentage of vessels within the villi – 26.9% [20.9%; 35.6%]. The reduction in vessel percentage in Group II.2 – 29.0% [25.6%; 34.2%] was associated with fibrosis of the chorionic villous stroma. These indicators significantly differed (p<0.0001) from Group I.1 and II.1: 45.2% [40.9%; 48.3%] and 57.6% [50.2%; 64.1%], respectively, and from the comparison group: 67.8% [58.78%; 73.7%]. Compensatory changes, such as an increase in syncytial knots, were observed in Subgroup I.2 and Subgroup II.1, with densities of 12.8 [11; 14] and 9.1 [8; 10], respectively, compared to 5.7 [5; 7] in the comparison group. A reduction in the percentage of the intervillous space was observed in Subgroup I.2 and Subgroup II.1: 26.0% [20.7%; 33.8%] and 29.2% [18.9%; 42.2%], respectively, versus 44.9% [40.5%; 49.6%] in the comparison group; p<0.0001. Placentitis is the main pathomorphological difference in placental changes in COVID-19 compared to preeclampsia. Pathomorphological changes in the placenta during the acute phase of COVID-19 and in mild preeclampsia, despite differences in disease pathogenesis, shared common features: microcirculatory disturbances and an increased number of syncytial knots as a compensatory response to reduced intervillous space (caused by villous stromal edema in COVID-19 and angiomatous changes in terminal villi in preeclampsia). Placental changes in moderate and severe preeclampsia, characterized by infarctions, arteriolosclerosis, and delayed villous maturation (distal villous hypoplasia), were similar to changes observed in COVID-19 in the second trimester of pregnancy.

  • Open Access

    PATHOMORPHOLOGICAL CHANGES OF THE PLACENTA IN THE ACUTE PERIOD OF CORONAVIRUS DISEASE 2019 (COVID-19) AT 37–41 WEEKS OF GESTATION

    by Tetiana Savchuk, Tetiana Malysheva, Viktoriya Vaslovych, Oksana Chernenko, Ivan Leshchenko, Sergiy Gychka

    Introduction: Coronavirus disease 2019 (COVID-19) is a risk factor for developing placental dysfunction when a pregnant woman is infected before 35 weeks of gestation. According to our previous studies, no cases of antenatal asphyxia were observed when infection occurred after this gestational age. The children were born with high Apgar scores and negative PCR tests for SARS-CoV-2 RNA from women who had clinical manifestations of COVID-19 confirmed by a positive PCR test. Objective of the Study: To investigate the pathomorphological changes in the placenta during full-term pregnancy in the acute phase of COVID-19 in women. Materials and Methods: The placenta (n=37) was studied at the birth of a live full-term fetus (main group) and compared to placentas from physiological deliveries before the COVID-19 pandemic (n=38, comparison group). Comprehensive morphological methods were used, including macroscopic, microscopic, immunohistochemical, electron-microscopic, morphometric, and statistical. Results: Structural changes were noted in the syncytiotrophoblast of the placenta, including loss of microvilli, nuclear membrane invaginations, appearance of cytoplasmic vacuoles, apoptosis, and chromatin condensation. In the endothelium, apoptosis, swelling, and mitochondrial homogenization were observed. Spherical structures similar to viral particles with an electron-dense membrane were found extracellularly, outside the fibroblast. The structural features indicated endothelial dysfunction and circulatory disorders – 97.3% (95% CI: 89.4%–100%); placentitis – 100% (95% CI: 94.6%–99.5%). Swelling of the chorionic villi was observed in 97.3% (95% CI: 89.4%-100%), with the percentage of stroma in the terminal villi increasing to 71.1 [49.5; 85.1] compared to 32.6 [26.2; 39.5] in the comparison group (p < 0.0001). A reduction in the percentage of vessels in the terminal villi was noted due to a decrease in lumen size – 29.9 [14.5; 51.2] compared to 67.4 [58.7; 73.8] in the comparison group (p < 0.0001); and a reduction in the percentage of the intervillous space to 21.7 [12.9; 33.1] compared to 44.2 [40.3; 49.7] (p < 0.0001). Conclusions: In the acute phase of COVID-19, pathomorphological changes were observed in the placenta, indicating endothelial dysfunction caused by SARS-CoV-2. This was manifested by circulatory disorders, swelling of the stroma of the chorionic villi with a reduction in capillary lumen size and the percentage of free intervillous space, and inflammatory infiltration, leading to maternal and fetal malperfusion in the placenta. In our opinion, pathology changes in the structures forming the vasculosyncytial membranes were compensated by the already-formed placenta with sufficient terminal villi and local placentitis (limited to one cotyledon). Apoptotic changes in the syncytiotrophoblast and endothelium are morphological manifestations of hypoxia and energy deficiency in the placenta. These changes require further investigation in the context of the prolonged post-COVID interval in pregnant women infected with the SARS-CoV-2 virus during the second trimester.


  • Open Access

    Pathomorphological changes of the placenta in coronavirus disease (COVID-19)

    by T. V. Savchuk, S. H. Gychka, I. V. Leshchenko

    The aim of this research was to study the pathomorphological changes in the placenta in case of coronavirus disease (COVID-19) in the anamnesis during different periods of gestation. Materials and methods. 53 placentas of women with the coronavirus disease (COVID-19) (RNA determination of the SARSCoV-2) during the pregnancy were studied. The material was divided into the following groups: 1 and 2 - placentas in cases with a negative PCR test in full-term newborns who were born in satisfactory condition and high Apgar score. Group 1 (n = 29) - mother's history of COVID-19 at 34-39 weeks of gestation; group 2 (n = 17) - mother's history of COVID-19 at 23-33 weeks of gestation; 3 (n = 7) - placenta in case of antenatal fetal death. Results. Statistically significant differences were revealed between study groups: chorioamnionitis prevailed in group 1 (in 28 cases (96.6 %); confidence interval (CI): 86.4-100.0 %; P1-2 = 0.004); in groups 2 and 3 - arteriosclerosis (in 13 cases (76.5 %); CI: 52.2- 93.9 %; P1-2 = 0.0003 and in 7 cases (100 %); CI: 75.7-100.0 %; P1-3 = 0.001; respectively). COVID-19 was diagnosed in group 1 from 34 to 39 weeks of gestation (median 36.5), group 2 from 23 to 33 weeks (median 28.0), in group 3 from 13 to 32 weeks with a median of 24.5. Antenatal fetal death was observed between 14 and 41 weeks (median 31.4). Conclusions. Pathomorphological changes in the placenta in the coronavirus disease COVID-19 depended on the duration of the post-COVID interval (the time interval from the diagnosis of COVID-19 and the moment of delivery), due to the sequential change in the phases of the inflammatory process: alteration, exudation and proliferation, followed by fibrosis. The formation of acute placental insufficiency in coronavirus disease COVID-19, diagnosed up to 1-6 weeks to delivery, is associated with the development of severe disorders of circulation and acute exudative inflammatory reactions of varying severity. The formation of chronic placental insufficiency is associated with the proliferative stage of inflammation. These changes lead to the development of fibrosis in the wall of arterioles and intervillous space. The most significant structural changes in the placenta, leading to placental insufficiency, were observed in group 2 - at the time of infection in the period from 23-33 weeks of pregnancy. Coronavirus disease COVID-19 in the mother in the second trimester of pregnancy is a risk factor for perinatal losses, which are caused by the changes in the placenta described above with an increase in the duration of the post-COVID interval.